Strategic Mandate This is a strategic initiative that fosters collaboration between pharmaceutical companies and startups to accelerate the development and market adoption of innovative medical and pharmaceutical solutions. Healthcare Innovation (HCI) acts as the central convener, bridge, and ecosystem manager for this process, ensuring that the needs of major industry players are matched with the agility of our incubated startups.

Program in Action Our open innovation process operates at three distinct levels to ensure maximum impact, from high-level strategy down to grassroots ideation:

1. Top-Down Strategy: We convene industry leaders, academic experts, and regulatory bodies to shape national policy and co-define a pragmatic roadmap for digital health investment and development.
2. Horizontal Market Access: We position our cluster and its startups in new international markets, leading strategic delegations to engage with global pharma leaders and build Euro-Mediterranean and regional synergies.
3. Bottom-Up Ideation: We embed the pharmaceutical industry’s needs at the very beginning of the innovation pipeline, ensuring our pre-incubation programs are solving validated, real-world problems.

Flagship Initiatives & Ventures

1. The HCI Summit: A high-level strategic think tank organized by HCI within the Co-Workup 4.0 program. This event brought together +40 key players, including 7 major pharmaceutical laboratories and 6 regulatory institutions, to define a pragmatic national roadmap and transform policy into pilot projects.
2. Algiers Slush’D Delegation: A strategic HCI delegation to a premier event co-organized by the pharmaceutical company ROCHE and Algeria Venture. The mission was to forge collaborations, boost HealthTech innovation, and create synergies between the Tunisian and Algerian ecosystems.
3. MedInTechs Paris Delegation: Our official presence at the premier MedInTechs event in Paris, aimed at strengthening HCI’s position in the European market and exploring high-level collaborations in AI-driven solutions and medical devices.

Pharma 4 Novation Partnership: The formal integration of industry partner Opalia Recordati into our pre-incubation program. Opalia provides the “Real-World Challenges” for our teams of young pharmacists to tackle, ensuring market relevance from day one.

Ecosystem & Key Partners

• ROCHE (Pharmaceutical Partner, Algiers Slush’D)
• Opalia RECORDATI (Industry Partner, Pharma 4 Novation)
• Algeria Venture (Ecosystem Partner, Algiers Slush’D)
• GIZ (Institutional Supporter, Co-Workup 4.0 Program)
• ANIMA Investment Network (Institutional Supporter, Co-Workup 4.0 Program)